Synthesis, characterization, and evaluation of mPEG–SN38 and mPEG–PLA–SN38 micelles for cancer therapy

References

• PommierYDNA Topoisomerase I inhibitors: Chemistry, biology, and interfacial inhibitionChem Rev200910972894290219476377
   PubMed Web of Science ®Google Scholar
• UlukanHSwaanPWCamptothecins: a review of their chemotherapeutic potentialDrugs200262142039205712269849
   PubMed Web of Science ®Google Scholar
• Zeghari-SqualliNRaymondECvitkovicEGoldwasserFoCellular pharmacology of the combination of the DNA topoisomerase I inhibitor SN-38 and the diaminocyclohexane platinum derivative oxaliplatinClin Cancer Res1999551189119610353756
   PubMed Web of Science ®Google Scholar
• WuMHYanBHumerickhouseRDolanMEIrinotecan activation by human carboxyl esterases in colorectal adenocarcinoma cellsClin Cancer Res2002882696270012171903
   PubMed Web of Science ®Google Scholar
• ZhangJAXuanTParmarMDevelopment and characterization of a novel liposome-based formulation of SN-38Int J Pharm20042709310714726126
   PubMed Web of Science ®Google Scholar
• AtyabiFFarkhondehfaiAEsmaeiliFDinarvandRPreparation of pegylated nano-liposomal formulation containing SN-38: In vitro characterization and in vivo biodistribution in miceActa Pharm200959213314419564139
   PubMed Web of Science ®Google Scholar
• MertOEsendaglGDoganALDemirASInjectable biodegradable polymeric system for preserving the active form and delayed-release of camptothecin anticancer drugsRSC Advances201221176185
   Web of Science ®Google Scholar
• LedermannJALeonardPSeymourMRecommendation for caution with irinotecan, fluorouracil, and leucovorin for colorectal cancerN Engl J Med2001345214514611450667
   PubMedGoogle Scholar
• ChabotGClinical pharmacokinetics of irinotecanClin Pharmacokinet19973342452599342501
   PubMed Web of Science ®Google Scholar
• DanksMTopoisomerase enzymes as drug targetsSchwabMEncyclopedic Reference of CancerBerlin/HeidelbergSpringer2001900903
   Google Scholar
• SlatterJGSchaafLJSamsJPPharmacokinetics, metabolism, and excretion of irinotecan (CPT-11) Following I.V. infusion of [14C] CPT-11 in cancer patientsDrug Metab Dispos200028442343310725311
   PubMed Web of Science ®Google Scholar
• ShimadaYRothenbergMHilsenbeckSGBurrisHAIDegenDVon HoffDDActivity of CPT-11 (irinotecan hydrochloride), a topoisomerase I inhibitor, against human tumor colony-forming unitsAnti-Cancer Drugs1994522022068049503
   PubMed Web of Science ®Google Scholar
• UlukanHMullerMTSwaanPWDownregulation of topoisomerase I in differentiating human intestinal epithelial cellsInt J Cancer200194220020711668498
   PubMed Web of Science ®Google Scholar
• EbrahimnejadPDinarvandRSajadiAPreparation and in vitro evaluation of actively targetable nanoparticles for SN-38 delivery against HT-29 cell linesNanomed Nanotech Biol Med201063478485
   PubMed Web of Science ®Google Scholar
• LeiSChienP-YSheikhSZhangAAliSAhmadIEnhanced therapeutic efficacy of a novel liposome-based formulation of SN-38 against human tumor models in SCID miceAnti Cancer Drugs200415877377815494639
   PubMed Web of Science ®Google Scholar
• DuncanRPolymer conjugates as anticancer nanomedicinesNat Rev Cancer20066968870116900224
   PubMed Web of Science ®Google Scholar
• LiCWallaceSPolymer-drug conjugates: Recent development in clinical oncologyAdv Drug Deliv Rev200860888689818374448
   PubMed Web of Science ®Google Scholar
• ZhaoHRubioBSapraPNovel prodrugs of SN38 using multiarm poly(ethylene glycol) linkersBioconjug Chem200819484985918370417
   PubMed Web of Science ®Google Scholar
• ÇirpanliYBilensoyELale DoğanAÇalişSComparative evaluation of polymeric and amphiphilic cyclodextrin nanoparticles for effective camptothecin deliveryEur J Pharm Biopharm2009731828919442723
   PubMed Web of Science ®Google Scholar
• SapraPKraftPMehligMMarked therapeutic efficacy of a novel polyethylene glycol-SN38 conjugate, EZN-2208, in xenograft models of B-cell non-Hodgkin’s lymphomaHaematologica200994101456145919794091
   PubMed Web of Science ®Google Scholar
• SapraPZhaoHMehligMNovel delivery of SN38 markedly inhibits tumor growth in xenografts, including a camptothecin-11-refractory modelClin Cancer Res20081461888189618347192
   PubMed Web of Science ®Google Scholar
• DongYFengS-SMethoxy poly(ethylene glycol)-poly(lactide) (MPEG-PLA) nanoparticles for controlled delivery of anticancer drugsBiomaterials200425142843284914962562
   PubMed Web of Science ®Google Scholar
• KimJ-HEmotoKIijimaMCore-stabilized polymeric micelle as potential drug carrier: increased solubilization of taxolPolym Adv Technol19991011647654
   Web of Science ®Google Scholar
• KimSCKimDWShimYHIn vivo evaluation of polymeric micellar paclitaxel formulation: toxicity and efficacyJ Control Release20017219120211389998
   PubMed Web of Science ®Google Scholar
• LuLZhengYWengSComplete 1 regression of xenograft tumors using biodegradable mPEG-PLA-SN38 block copolymer micellesColloids Surf B Biointerfaces201614241742326994941
   PubMed Web of Science ®Google Scholar
• KoizumiFKitagawaMNegishiTNovel SN-38a-incorporating polymeric micelles, NK012, eradicate vascular endothelial growth factor – secreting bulky tumorsCancer Res20066620100481005617047068
   PubMed Web of Science ®Google Scholar
• KimSYLeeYMBaikDJKangJSToxic characteristics of methoxy poly(ethylene glycol)/poly(ε-caprolactone) nanospheres; in vitro and in vivo studies in the normal miceBiomaterials2003241556312417178
   PubMed Web of Science ®Google Scholar
• LigginsRTHunterWLBurtHMSolid-state characterization of paclitaxelJ pharm sci19978612145814639423162
   PubMed Web of Science ®Google Scholar
• MaedaHMacromolecular therapeutics in cancer treatment: The EPR effect and beyondJ Control Release2012164213814422595146
   PubMed Web of Science ®Google Scholar
• TorchilinVPStructure and design of polymeric surfactant-based drug delivery systemsJ Control Release2001732–313717211516494
   PubMed Web of Science ®Google Scholar
• El-SeragHBRudolphKLHepatocellular carcinoma: epidemiology and molecular carcinogenesisGastroenterology200713272557257617570226
   PubMed Web of Science ®Google Scholar
• CurleySAIzzoFRadiofrequency ablation of primary and metastatic hepatic malignanciesAnnals of Surgery199923011810400029
   PubMed Web of Science ®Google Scholar
• LogueSEElgendyMMartinSJExpression, purification and use of recombinant annexin V for the detection of apoptotic cellsNat Protoco20094913831395
   Web of Science ®Google Scholar
• XiaHGaoXGuGPenetratin-functionalized PEG -PLA nanoparticles for brain drug deliveryInternational Journal of Pharmaceutics20124361–284085022841849
   PubMed Web of Science ®Google Scholar
• ZhengNDaiWDuWA novel lanreotide-encoded micelle system targets paclitaxel to the tumors with overexpression of somatostatin receptorsMol Pharm2012951175118822435704
   PubMedGoogle Scholar
• AcharyaSSahooSKPLGA nanoparticles containing various anticancer agents and tumour delivery by EPR effectAdv Drug Deliv Rev201163317018320965219
   PubMed Web of Science ®Google Scholar